The designation covers Bright Path’s end-to-end U.S. production of two hospital medicines in chronic shortage, the first proof that essential medicines can be made in America, in most cases at prices that beat China and IndiaContinue reading
Author Archive: AZBio
Arizona Innovation Challenge 2026 – SAS Companies
The Arizona Innovation Challenge (AIC), one of the largest business plan competitions in the country, is designed to advance innovation and technology commercialization opportunities in Arizona by assisting early-stage ventures to scale. All applicants receive feedback on their business plan from experienced entrepreneurial judges.
AIC awardees receive $100,000 of non-dilutive funding and three months of customized support with an ACA-designated partner.Continue reading
TD2 Oncology is the 2026 Arizona Bioscience Company of the Year
Transforming Global Oncology from the Heart of Arizona:
Arizona Bioscience Company of the Year – TD2 OncologyContinue reading
HHS Announces Key Leadership Selections at FDA to Promote Innovation, Reform, and National Health Priorities
WASHINGTON, D.C. — September 8, 2026 — The U.S. Department of Health and Human Services today announced the selection of four senior leaders at the U.S. Food and Drug Administration (FDA), strengthening the agency’s leadership team as FDA advances its public health pillars to deliver profound benefits for patients, consumers, and public health. These appointments reflect a deliberate strategy to drive innovation and meaningful reform across FDA, positioning the Agency to lead on its core priorities: advancing innovation and global leadership, strengthening national health security, increasing access to affordable medicines and medical products, and promoting health wellness for the American people.
This Fast Lane Company is Saving Lives One Heart at a Time
A vital lifeline to patients facing end-stage biventricular heart failure.
For millions of people worldwide, cardiac health is something taken for granted—a steady, rhythmic beat keeping life in motion. But for patients diagnosed with advanced biventricular heart failure, that rhythm slows to a dangerous point. When both the left and right ventricles can no longer pump enough blood to sustain vital organs, the threat of imminent death becomes an immediate reality.
In these critical moments, modern medical technology steps in with a groundbreaking solution: the SynCardia Total Artificial Heart (STAH)Continue reading
He learned to be a scientist as a teenager. Now he seeks a cure for a childhood cancer.
He learned to be a scientist as a teenager. Now he seeks a cure for a childhood cancerContinue reading
Alzheimer’s research pioneer announces leadership transition after 38 years at Banner Health
Dr. Eric M. Reiman’s groundbreaking work transformed Alzheimer’s research and positioned Banner as a global leader in detection, prevention studiesContinue reading
Senphonix Receives National Science Foundation Grant to Advance SleeveSense, a Continuous, Long-Term Vitals Monitoring Platform
Federal funding backs engineering to advance the wireless and radio-frequency systems for the wearable toward manufacturing at scale, in partnership with the University of ArizonaContinue reading
Precision Epigenomics Named an AZBio Fast Lane Company
Detecting Cancer Before It Starts: How One Arizona Startup Is Transforming Precision Oncology
In modern medicine, early cancer detection remains a central goal. Identifying a tumor before symptoms emerge often makes the difference between routine intervention and a terminal diagnosis.
Standing at the leading edge of this shift is Precision Epigenomics, a Tucson-based bioscience startup whose rapid trajectory over the past 18 months is drawing national attention. Through cutting-edge liquid biopsy technology, rigorous laboratory standards, and high-impact strategic partnerships, the company is turning complex epigenetic science into life-saving clinical tools.Continue reading
Evidence Matters: Navigating the 2026–2027 Respiratory Virus Season
As Arizona enters another respiratory virus season, physicians will once again navigate patient questions surrounding influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) immunization. In an environment of evolving recommendations and competing information, access to rigorous, transparent evidence is essential to informed clinical decision-making.Continue reading